(Q53752727)

19 May 2018

title

Adipose tissue-derived stem cells show both immunogenic and immunosuppressive properties after chondrogenic differentiation (English)

1 reference

https://api.crossref.org/works/10.3109/14653249.2010.504769

2 July 2024

author name string

Antje Technau

1

1 reference

19 May 2018

Katrin Froelich

2

1 reference

19 May 2018

Rudolf Hagen

3

1 reference

19 May 2018

Norbert Kleinsasser

4

1 reference

19 May 2018

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20795757

2 July 2024

publication date

26 August 2010

1 reference

19 May 2018

full work available at URL

https://api.elsevier.com/content/article/PII:S1465324911705072?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.3109/14653249.2010.504769

https://api.elsevier.com/content/article/PII:S1465324911705072?httpAccept=text/plain

2 July 2024

1 reference

https://api.crossref.org/works/10.3109/14653249.2010.504769

2 July 2024

1 reference

19 May 2018

volume

13

1 reference

19 May 2018

issue

3

1 reference

19 May 2018

page(s)

310-317

1 reference

19 May 2018

Multilineage potential of adult human mesenchymal stem cells

cites work

1

1 reference

https://api.crossref.org/works/10.3109/14653249.2010.504769

Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing.

2 July 2024

2

1 reference

https://api.crossref.org/works/10.3109/14653249.2010.504769

Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex

2 July 2024

3

1 reference

https://api.crossref.org/works/10.3109/14653249.2010.504769

Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo

2 July 2024

4

1 reference

https://api.crossref.org/works/10.3109/14653249.2010.504769

Human mesenchymal stem cells modulate allogeneic immune cell responses

2 July 2024

5

1 reference

https://api.crossref.org/works/10.3109/14653249.2010.504769

Immunomodulatory properties of mesenchymal stromal cells

2 July 2024

6

1 reference

https://api.crossref.org/works/10.3109/14653249.2010.504769

Multilineage cells from human adipose tissue: implications for cell-based therapies

2 July 2024

7

1 reference

https://api.crossref.org/works/10.3109/14653249.2010.504769

Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease

2 July 2024

8

1 reference

https://api.crossref.org/works/10.3109/14653249.2010.504769

Immunomodulatory effect of human adipose tissue-derived adult stem cells: comparison with bone marrow mesenchymal stem cells

2 July 2024

9

1 reference

https://api.crossref.org/works/10.3109/14653249.2010.504769

Expanded adipose-derived stem cells suppress mixed lymphocyte reaction by secretion of prostaglandin E2.

2 July 2024

10

1 reference

https://api.crossref.org/works/10.3109/14653249.2010.504769

Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis

2 July 2024

11

1 reference

https://api.crossref.org/works/10.3109/14653249.2010.504769

Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells

2 July 2024

12

1 reference

https://api.crossref.org/works/10.3109/14653249.2010.504769

HLA expression and immunologic propertiesof differentiated and undifferentiated mesenchymal stem cells

2 July 2024

13

1 reference

https://api.crossref.org/works/10.3109/14653249.2010.504769

Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells

2 July 2024

14

1 reference

https://api.crossref.org/works/10.3109/14653249.2010.504769

Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

2 July 2024

15

1 reference

https://api.crossref.org/works/10.3109/14653249.2010.504769

GVHD: a continuing barrier to the safety of allogeneic transplantation

2 July 2024

16

1 reference

https://api.crossref.org/works/10.3109/14653249.2010.504769

L-Sox5, Sox6 and Sox9 control essential steps of the chondrocyte differentiation pathway

2 July 2024

17

1 reference

https://api.crossref.org/works/10.3109/14653249.2010.504769

Control of cell fate and differentiation by Sry-related high-mobility-group box (Sox) transcription factors

2 July 2024

18

1 reference

https://api.crossref.org/works/10.3109/14653249.2010.504769

L-Sox5 and Sox6 drive expression of the aggrecan gene in cartilage by securing binding of Sox9 to a far-upstream enhancer

2 July 2024

19

1 reference

https://api.crossref.org/works/10.3109/14653249.2010.504769

Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells.

2 July 2024

20

1 reference

https://api.crossref.org/works/10.3109/14653249.2010.504769

HLA-G is a crucial immunosuppressive molecule secreted by adult human mesenchymal stem cells

2 July 2024

21

1 reference

https://api.crossref.org/works/10.3109/14653249.2010.504769

2 July 2024

Adipose-derived cells

22

1 reference

https://api.crossref.org/works/10.3109/14653249.2010.504769

Cytokine profile of human adipose-derived stem cells: expression of angiogenic, hematopoietic, and pro-inflammatory factors.

2 July 2024

23

1 reference

https://api.crossref.org/works/10.3109/14653249.2010.504769

An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation

2 July 2024

24

1 reference

https://api.crossref.org/works/10.3109/14653249.2010.504769

Interferon-gamma-stimulated marrow stromal cells: a new type of nonhematopoietic antigen-presenting cell

2 July 2024

25

1 reference

https://api.crossref.org/works/10.3109/14653249.2010.504769

Antigen-presenting property of mesenchymal stem cells occurs during a narrow window at low levels of interferon-gamma

2 July 2024

26

1 reference

https://api.crossref.org/works/10.3109/14653249.2010.504769

Mesenchymal stem cell-based HLA-independent cell therapy for tissue engineering of bone and cartilage

2 July 2024

28

1 reference

https://api.crossref.org/works/10.3109/14653249.2010.504769

Articular cartilage reconstruction using xenogeneic epiphyses slices

2 July 2024

29

1 reference

https://api.crossref.org/works/10.3109/14653249.2010.504769

Distribution of class I and II human leukocyte antigens in the larynx.

2 July 2024

30

1 reference

https://api.crossref.org/works/10.3109/14653249.2010.504769

Laryngeal transplantation in the setting of cancer: a rat model

2 July 2024

31

1 reference

https://api.crossref.org/works/10.3109/14653249.2010.504769

Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting

2 July 2024

32

1 reference

https://api.crossref.org/works/10.3109/14653249.2010.504769

Mesenchymal stem cells fail to trigger effector functions of cytotoxic T lymphocytes

2 July 2024

33

1 reference

https://api.crossref.org/works/10.3109/14653249.2010.504769

2 July 2024

Identifiers

1 reference

19 May 2018

1 reference

19 May 2018